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Summal'y 
During antigen recognition by T  cells, CD4 and the T-cell receptor (TCR)/CD3/~" complex 
are thought to interact with the same major histocompatibility complex II molecule in a stable 
ternary complex. Evidence has suggested that the association  of CD4 with TCR/CD3/~" re- 
quires the interaction of the protein tyrosine kinase p56  ~k with CD4. We have taken a biochem- 
ical approach to understand the mechanism by which p56  ~  and, in particular,  its src homology 
(SH) 2 domain contributes to the association  of CD4 with TCK/CD3/~" during activation. 
We have previously shown that the p56  kk SH2 domain binds directly to tyrosine-phosphorylated 
ZAP-70. Here we formally demonstrate the in vivo association of p56  ~k with the homologous 
protein tyrosine kinases  Syk and ZAP-70 after  CD3 stimulation of Jurkat cells. A  tyrosine- 
phosphorylated peptide containing the sequence predicted to be optimal for binding to the SH2 
domain of src family kinases specifically competes for this association,  indicating that tyrosine- 
phosphorylated ZAP-70 and Syk bind to p56  kk by an SH2-mediated interaction. We also show 
that the same peptide is able to compete for the activation-dependent TCR/CD4 association 
in Jurkat cells. Moreover, ZAP-70 and CD4 cocap only after CD3 stimulation in human T lym- 
phoblasts. We propose that the interaction of the p56  ~k SH2 domain with ~'-associated tyrosine- 
phosphorylated ZAP-70 and/or Syk enables CD4 to associate  with antigen-stimulated TCR/CD3/~" 
complexes. 
E 
ngagement of the TCR by antigen bound to MHC mol- 
ecules activates a protein tyrosine kinase (PTK) ~ path- 
way, resulting in tyrosine phosphorylation of a number of 
cellular proteins (1). At least four PTKs have been shown 
to be implicated in this process: two kinases of the src family 
(p56 t'k and p59fr") (2-6) and two of the Syk family (ZAP- 
70 and Syk) (7-13).  Their respective contributions to TCR 
signaling,  however, are not precisely understood. 
The current model of antigen/MHC-induced T cell acti- 
vation is based on a sequential interaction of these PTKs with 
the TCR/CD3/~" complex, which by itself lacks intrinsic ki- 
nase activity (14). One of the earliest detectable events after 
TCK triggering is the tyrosine phosphorylation of the CD3/~" 
chains  (15, 16)  on  antigen  recognition activation  motifs 
(ARAMs) that are present within the cytoplasmic domain 
of the CD3/~" chains (17-19). p56  t'k or p59frn is thought to 
be the kinase responsible for this early phosphorylation event 
(20, 21). This in turn should lead to the recruitment of the 
tyrosine kinase ZAP-70, most likely by an interaction medi- 
i Abbreviations  used in this paper: ARAM, antigen recognition activation 
motif;  PTK, protein  tyrosine kinase; SH,  src homology. 
ated by src homology (SH)2 domain (7, 22, 23). A similar 
mechanism of recruitment has been proposed for the Syk tyro- 
sine kinase (12), although recent studies by Couture et al. 
(13) have shown that Syk may be constitutively associated 
with TCK/CD3/~'. TCR stimulation also leads to tyrosine 
phosphorylation and activation of ZAP-70 and Syk (refer- 
ences 7 and 13 and our own unpublished results). 
In view of the dramatic increase in cellular tyrosine phos- 
phorylation after TCR triggering, additional interactions be- 
tween the src and Syk families of PTKs are likely to occur 
within the activated TCR complex. Cotransfection experi- 
ments in COS cells and in a human cytotoxic T lymphocyte 
line have demonstrated a functional cooperation of these two 
classes of PTKs (8, 9, 12, 21). We have recently reported that 
a direct physical interaction between p56  ~k and ZAP-70 can 
occur during the course of T cell activation  and that p56  ~k 
binds, via its SH2 domain, to tyrosine-phosphorylated ZAP- 
70 after anti-CD3 stimulation of Jurkat cells (24). We have 
proposed that this interaction takes place as soon as ZAP-70 
is phosphorylated on an unknown tyrosine residue that serves 
as an adaptor site for the SH2 domain of p5C  k. In addition, 
an SH2-mediated interaction of p5C  k with Syk has recently 
been proposed based on in vitro data (13), and an association 
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treated LSTKA cells (25). 
We and others (13, 24) have also suggested that an SH2- 
mediated interaction between  p56 ~  and  ZAP-70  or  Syk 
could  mediate  the  recruitment  of p56  t'k  to  the  activated 
TCR, allowing p56 ~k to interact with and/or to phosphory- 
late other effector molecules.  The interaction of p56 t'k with 
CD4 or CD8 provides another clue to the possible contribu- 
tion of p56 I'k to TCR signaling. It has been proposed that 
CD4-associated  p56 ~k  anchors  CD4  and  the  stimulated 
TCR/CD3/~'complex to the same MHC molecule (26). In- 
deed, by using fluorescence resonance energy transfer, colocali- 
zation of CD4 and the TCK/CD3/~" complex has been shown 
to be dependent on the association  of p56 ~k and CD4 (27). 
In addition, the TCK/CD4 association may be mediated by 
the binding of the SH2 domain of CD4-associated p56 ~  to 
phosphotyrosine residues within activated TCR/CD3/~" (28). 
However, the target protein(s) binding to the SH2 domain 
of p56 t~k has not been identified in  these studies. 
We have taken a biochemical approach to study the poten- 
tial contribution of the p56 t'~ SH2 domain to the clustering 
of CD4 and TCK/CD3/~'. We demonstrate that the SH2 
domain  of CD4-associated  p56 ~k binds  to  two  tyrosine- 
phosphorylated proteins, ZAP-70  and Syk, after anti-CD3 
activation of  Jurkat cells. We also show biochemical evidence 
for  an  SH2-dependent  association  of  p56/cUCD4  with 
TCR/CD3/~'. In addition, ZAP-70 is shown to colocalize 
with CD4 in activated T lymphoblasts. Based on these data, 
we propose that the interaction of the SH2 domain of CD4- 
associated p56 ~k with tyrosine-phosphorylated, ~'-associated 
ZAP-70 and/or Syk is responsible for the activation-dependent 
association  of CD4 with the TCK/CD3/~" complex. 
Materials and Methods 
Cells Lines and Antibodies.  Jurkat cells, clone 77-6.8 (a gift from 
Dr. K. A. Smith, Dartmouth Medical  School, Hanover, NH), were 
grown  in  RPMI  1640 medium supplemented with 10%  FCS 
(KPMI-FCS), 2 mM L-glutamine, penicillin, and streptomycin. 
CD4-  and  CD4 + clones were derived from  clone 77-6.8 by 
fluorescence-activated  cell sorting and cloning. Human T lympho- 
blasts were obtained by culturing PBMCs at a concentration of 
106 cells/ml in RPMI-FCS with 2 #g/ml PHA (WeUcome  Indus- 
tries, Beckenham, UK) for 5 d. After washing, the cells were ex- 
panded and maintained in RPMI-FCS supplemented with recom- 
binant human Ib2 (50 IU/ml; kindly provided by P. Dellabona, 
Dipartimento di Biologia e Tecnologia, Milano, Italy). 
mAbs used  included  CBT3 (29) (kindly  provided  by L. De Monte, 
University of Turin, Turin, Italy) and biotin-labeled Leu4 (Becton 
Dickinson & Co., Mountain View, CA), both specific for human 
CD3; anti-CD3e (2Ad2A2, IgM) and anti-TCR VB8 (5Rex-9H5, 
IgG2a) (kindly provided by E. Reinhertz, Dana Farber Cancer In- 
stitute, Boston, MA); anti-human CD4 B66.6.1 (IgG1; a gift of 
B. Perussia,  Jefferson  Cancer Center, Philadelphia, PA), 19Thy-5D7 
(IgG2a; kindly provided  by E. Reinherz), and biotin-labeled  Leu3a 
(Becton Dickinson); and antiphosphotyrosine (4G10, IgG2b; Up- 
state Biotechnology Inc., Lake Placid, NY). 
Rabbit polyclonal antibodies used included anti-human  p56  kk 
kinase directed against the COOH-terminal  region (Upstate Bio- 
technology Inc.); anti-p56  ~  serum directed against a synthetic 
peptide corresponding to amino acids 39-64 of p56  uk (the NH2- 
terminal region; kindly provided by S. Fischer, H6pital Cochin, 
Paris, France); anti-p56  ~ serum raised against recombinant human 
p56 Ick and  antiphosphotyrosine serum (kindly provided by M. 
Gassmann and P. Burn, Hoffmann-La Roche Ltd., Basel, Switzer- 
land); anti-~" serum (a  gift from J.  Ravetch, Memorial Sloan- 
Kettering Institute, New York, NY); anti-Syk antiserum (K423; 
kindly provided by K. Robbins, National Institutes of Health, 
Bethesda, MD); and anti-ZAP-70 antiserum directed against a syn- 
thetic peptide corresponding to amino acids 485-499 of ZAP-70 
(produced in our laboratory  using KLH as a carrier as described [8]). 
Immunoprecipitations.  Jurkat cells were washed twice in KPMI 
1640 medium and resuspended at  10  s cells/ml in  RPMI  1640. 
Cells were preincubated for 10 min at 37~  and stimulated with 
anti-CD3 mAb (2Ad2A2 at 1:200 dilution of ascities) for the time 
indicated. Cells were harvested and solubilized at 10  s cells/ml for 
30 min at 4~  in 1% Brij 96 or 1% NP-40 lysis  buffer containing 
20 mM Tris-HC1, pH 7.5, 150 mM NaC1, 1 mM MgC12, and 1 
mM EGTA in the presence of inhibitors of proteases and phospha- 
tases (10 #g/rot leupeptin, 10/zg/ml aprotinin, 1 mM Pefabloc-sc 
[Interchim, Paris, France], 50 mM NaF, 10 mM Na4P2OT, and 1 
mM NaVO4). In peptide competition experiments, 100/xM un- 
phosphorylated or tyrosine-phosphorylated peptide was added to 
the lysis  buffer as indicated. Postnuclear  lysates  were precleared for 
1 h with mahose-binding protein-Sepharose beads and subjected 
to immunoprecipitation  for 2 h with antibodies preadsorbed to pro- 
tein A-Sepharose (Pharmacia Diagnostics AB, Uppsala, Sweden) 
or covalently coupled to protein A-Sepharose (30). Precipitation 
of SH2-binding proteins was done as described previously (24). 
Precipitates were washed twice in 1% detergent lysis  buffer without 
inhibitors and twice with 0.05% detergent lysis  buffer and boiled 
in sample buffer before electrophoresis. 
Biotinylation of Cell Surface Proteins.  Jurkat cells were washed 
twice in PBS (10 mM phosphate buffer, pH 7.4, 2.7 mM KC1, 
and 137 mM NaC1) and resuspended at  10  s cells/ml in 5 mM 
NHS-I.C Biotin (Pierce Chemical Co., Rockford, IL) in PBS. Cells 
were incubated for 1 h at 4~  washed twice with 20 mM PBS- 
glycine, and twice in PBS, and finally resuspended in RPMI 1640 
medium at 10  s Cells/ml. Activation  and immunoprecipitations  were 
then performed as previously described. 
Imrnunoblotting.  Immunoblotting and detection  of proteins were 
performed as described  previously.  For detection ofbiotinylated pro- 
teins, blots were blocked in PBS plus 0.1% Tween 20 in the pres- 
ence of 5% BSA, incubated with a 1:3,000 dilution of streptavidin- 
biotinylated horseradish peroxidase complex (Amersham Interna- 
tional, Buckinghamshire, UK), and developed  with the enhanced 
chemiluminescence detection system (Amersham International). 
In Vitro Kinase Assay and Reimmunoprecipitation.  Immunocom- 
plexes were prepared as previously  described  except that an additional 
wash of the beads with kinase  buffer (25 mM Hepes, pH 7.3, 10 mM 
MnC12, 0.05% Brij 96) was performed. Reactions were started .by 
the  addition of 30  #1  of kinase buffer containing  10  #Ci  of 
['y3zp]ATP (3,000 Ci/mM),  incubated at room temperature under 
constant agitation, and stopped after 15 min by the addition of 2 ￿ 
sample buffer containing 10 mM EDTA. For reimmunoprecipita- 
tions, reactions  were stopped by adding 10 mM F_DTA. After washing 
twice with 1% Brij lysis  buffer, the beads were resuspended  in du- 
tion buffer containing 1% SDS and 2 mM DTT in 0.05% Brij lysis 
buffer with inhibitors. Samples were incubated at 68~  for 5 min 
and then cooled on ice. After addition of 20 mM iodoacetamide, 
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inhibitors and kept on ice for at least I h before reimmunoprecipita- 
tion. Samples were analyzed by SDS-PAGE. Gels were fixed, treated 
with 1 M KOH for 1 h at 55~  to remove the alkali-labile phos- 
phate groups from serine- and threonine-phosphorylated  proteins, 
dried,  and autoradiographed. 
Capping and  Immunofluorescence  Microsco~.  2-too-old,  PHA- 
activated human lymphoblasts at a concentration of 107 cells per ml 
in RPMI plus 5% FCS were incubated for 45 min with biotin-hbeled 
Leu4 or Leu3a (10 #g/ml). After washing, cells were incubated with 
fluorescein-conjugated  streptavidin  (Protos  Immunoresearch,  San 
Francisco, CA) at 5 #g/ml. All these steps were performed at 4~ 
After washing, the cells were either immediately plated on a poly- 
L-lysine-coated glass coverslip or shifted to 37~  for 5 min to in- 
duce capping and then plated. The cells were then fixed with 3% 
paraformaldehyde in PBS at room temperature for 7 min, permeabi- 
lized with 0.2% Tween 20 in PBS for 5 rain,  and immunolabeled 
with  a~nity-purified rabbit  antiphosphotyrosine,  anti-p56  ~,  or 
anti-ZAP-70  antisera,  followed by rhodamine-conjugated  F(ab')2 
fragments  of goat anti-rabbit IgG (Protos  Immunoresearch)  at 5 
/~g/ml. In the case of CD4 capping,  some of the cells were previ- 
ously incubated with CBT3 mAb,  washed,  and shifted  to 37~ 
for 1 rain to induce  CD3-mediated cell activation. 
Results 
Tyrosine-Phosphorylated Syk  and  ZAP-70  Bind  to  p56  Ic~ 
during T Cell Activation.  We have previously shown that after 
CD3  stimulation of Jurkat cells, p56 ~k associates with two 
tyrosine-phosphorylated proteins, the tyrosine kinase ZAP-70 
and another unidentified protein of '~74 kD  (24).  In addi- 
tion,  in an  in vitro  kinase assay,  we detected ZAP-70  and 
another tyrosine-phosphorylated protein of 72-74  kD  that 
binds to the SH2 domain of p56 tck after CD3 cross-linking, 
suggesting that the latter may also have tyrosine kinase ac- 
tivity. The protein tyrosine kinase Syk, a 72-kD homologue 
of ZAP-70,  has been shown to be well expressed in Jurkat 
cells  (12,  31)  and therefore represents  a likely candidate for 
the second unidentified protein  that coimmunoprecipitates 
with p56 ~k. 
To test this hypothesis, we performed immunoprecipita- 
tions of cellular extracts of activated and unstimulated Jurkat 
T  cells  with  anti-Syk,  anti-ZAP-70,  and  anti-p5C k anti- 
bodies followed by antiphosphotyrosine immunoblotting (Fig. 
1 A).  In anti-Syk immunoprecipitates,  Syk was detected as 
a tyrosine-phosphorylated band of 74 kD. Its tyrosine phos- 
phorylation strongly increased after Jurkat cell activation (the 
high basal level of tyrosine phosphorylation detected in this 
experiment was not consistently detected; see also Fig. 3, lanes 
3 and 4). Similarly, ZAP-70, migrating as a 68/70-kD  dou- 
blet, became heavily tyrosine phosphorylated after CD3 cross- 
linking, whereas only a small fraction of tyrosine-phosphory- 
lated ZAP-70 was detected in unstimulated cells after longer 
exposures (data not shown). ZAP-70 and Syk comigrated with 
tyrosine-phosphorylated proteins coprecipitating with p56 ~k 
after cell activation (Fig. 1 A). Their amounts were too low 
to be detectable by Western blotting using our anti-ZAP-70 
or anti-Syk antibodies.  To identify both proteins  formally, 
we performed reimmunoprecipitations of ZAPo70 and Syk 
from p56 Ic~ immunoprecipitates subjected to an in vitro ki- 
nase assay (Fig.  1 B).  In this  assay p56 ~k became  strongly 
labeled; in addition, a broad band of 70-74  kD became la- 
beled in the anti-p56 ~k precipitate after CD3 cross-linking. 
Reprecipitation experiments from this sample with specific 
anti-ZAP-70 and anti-Syk antisera clearly demonstrated that 
ZAP-70 and Syk form part  of the  70-74-kD  band  (Fig.  1 
B).  Furthermore,  the identification of the two kinases was 
confirmed  by  immunodepletion  and  antiphosphotyrosine 
Western blot analysis of anti-p56 ~k immunoprecipitates from 
activated cells (Fig.  2).  After immunodepletion of ZApo70 
(Fig. 2 A, lanes 3 and 4), the 68/70-kD doublet was no longer 
detectable in p56  ~k immunoprecipitates (lanes I  and 2). Con- 
versely, the 74-kD  band coprecipitating  with  p56 tck disap- 
peared after immunodepletion of Syk (Fig. 2 B). Importantly, 
Figure 1.  Syk and ZAP-70 bind to p56  J'k after T 
cell activation.  (A) Brij 96 lysates  were  prepared  from 
unstimulated  Jurkat cells (-) or from cells stimu- 
lated  with anti-CD3 for 2 min (+). Immunoprecipi- 
tations were performed using 107 cell equivalent 
with anti-Syk and anti-p56  ~k antibodies or 2.5  x 
106 cell equivalent with  anti-ZAP-70 antiserum. 
Samples  were loaded  on an 8% SDS-polyacrylamide 
gel and analyzed  by antiphosphotyrosine  immuno- 
blotting. The relative  positions of Syk and ZAP-70 
(migrating as a doublet) are shown by arrows. The 
p56  t'~ protein is indicated by open arrowheads. A 
longer exposure (3 rain instead of 20 s) is shown 
for anti-p56~ immunoprecipitates.  Positions  of mo- 
lecular mass markers are shown in kilodaltons. (B) 
Brij 96 lysate was prepared from 3  x  10Y Jurkat 
cells before (-) or after (+) stimulation  with anti- 
CD3 for 2 rain and subjected to immunoprecipitation  with anti-p56  ~k. Washed immunoprecipitates  were incubated in an in vitro kinase assay  with 
[3~-32p]ATP. One-third of the samples were directly etuted by boiling in sample buffer (p561'~), and (in the case of the sample from stimulated cells) 
the remaining  two-thirds were subjected  to reimmunoprecipitation  by anti-ZAP-70 or anti-Syk  antibodies (p56  kl -~ ZAP-70 and p56  ~ ~  Syk), respec- 
tively. Phosphorylated  proteins were analyzed  by 12% SDS-PAGE, KOH treated, and autoradiographed. A longer exposure (6 d instead of I d) is 
shown for reimmunoprecipitates. The relative positions of p56  ~, ZAP-70, and Syk are indicated. 
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ZAP-70 with p56~k (A) NP-40  lysates of 5 x  107 
activated cells were precleared by four successive 
rounds of  immunodepletions (//9) using either non- 
relevant (preimmune; NR) or anti-ZAP-70 (ZAP) 
antiserum, and half  of each sample  was immunopre- 
cipitated (IP) with anti-ZAP-70 or anti-p56  I'~ anti- 
bodies, as indicated. Samples were analyzed on an 
8% SDS-polyacrylamide  gel by antiphosphotyrosine 
immunoblotting. A shorter exposure  (5 s instead of 
10 min) is shown for anti-ZAP-70 immunoprecipi- 
tates. The positions of p56  ~k, ZAP-70, and Syk are 
indicated. (B) NP-40 lysates of 4  x  107 activated 
cells were predeared by five successive  rounds of 
immunodepletions (//9) using either nonrelevant (preimmune; NR) or anti-Syk (Syk) antiserum, and half of each sample was immunoprecipitated 
(IP) with anti-Syk or anti-p56  Ick antibodies as indicated. Samples  were analyzed on an 8% SDS-polyacrylamide  gel by antiphosphotyrosine immuno- 
blotting. A shorter exposure (20 s instead of 3 min) is shown for anti-Syk immunoprecipitates. 
immunodepletion  of ZAP-70 did  not  appear  to  affect  the 
p56~k/Syk  interaction (Fig. 2 A, lanes 1 and 2), nor did im- 
munodepletion of Syk affect the p561c~/ZAP-70 interaction 
(Fig.  2 B, lanes 1 and 2),  suggesting  that  Syk and ZAP-70 
bind  to independent  populations  of p56  ~k. 
Interaction of Tyrosine-Phosphorylated  Syk and ZAP-70 with 
the p56  ~k SH2 Domain.  After Jurkat  activation,  tyrosine- 
phosphorylated ZAP-70 binds to the SH2 domain of p56  ~k 
in vitro (24).  To test whether a similar  type of interaction 
occurs between p56  ~  and Syk,  we  analyzed  SH2-binding 
proteins and anti-Syk immunoprecipitates by antiphosphotyro- 
sine and anti-Syk immunoblotting (Fig.  3). In unstimulated 
Jurkat cells,  Syk migrated as a 72-kD band (Fig.  3, lane 7). 
After cell activation,  an  additional  more slowly migrating 
form of Syk could be detected by anti-Syk immunoblotting 
(Fig. 3, lane 8). Only this 74-kD species, which corresponds 
to the tyrosine-phosphorylated form of Syk (Fig. 3, lane 4), 
bound  to  the  SH2 domain  of p56  ~k after  activation  (lanes 
1,  2,  5,  and  6). 
To investigate whether the in vivo association of ZApo70 
and Syk with p56  ~  is an SH2-mediated interaction,  cellular 
Figure  3.  Tyrosine-phosphorylated  Syk binds to the SH2 domain of 
p56  ~ in vitro. NP-40  lysates  were prepared from 107 unstimulated  Jurkat 
cells (-) or 10  ~ cells stimulated with anti-CD3 for 2 rain (+)~ Proteins 
associated  with Sepharose-coupled  maltose-binding  protein SH2, and anti- 
Syk immunoprecipitates were separated on an 8% SDS-polyacrylamide 
gel and analyzed  by antiphosphotyrosine  or anti-Syk  immunoblotting. The 
positions of unphosphorylated and tyrosine-phosphorylated  Syk are indi- 
cated by open and closed arrowheads, respectively. 
extracts from unstimulated or activated Jurkat cells were lysed 
in the presence of an unphosphorylated or tyrosine-phosphor- 
ylated peptide corresponding to a sequence (YEEI) predicted 
to be  optimal  for binding  to  the  src  family  kinases  (32). 
Extracts  were analyzed  for  the  coprecipitation  of ZAP-70 
and Syk with p56  l'k using two different antibodies directed 
against  the NH2 and COOH  termini  of the p56  t'~ protein 
(Fig. 4 A).  Using either antibody, tyrosine-phosphorylated 
ZAP-70 and Syk were detected in anti-p56 k~ precipitates of 
activated cells (Fig. 4 A, lanes 2 and 5). The phosphorylated 
but  not  the  unphosphorylated  version  of the  p56  ~k  SH2 
competitor peptide was able to impede the association be- 
tween  p56  ~  and  the  Syk/ZAP  family  kinases  (Fig.  4  A, 
compare lanes 3 and 6 with lanes 2 and 5, respectively).  Under 
the same conditions,  the phosphorylated peptide competed 
efficiently for the binding  of tyrosine-phosphorylated  pro- 
teins  to the recombinant  SH2 domain of p56  t'~ (Fig.  4 A, 
lanes 7 and 8). We therefore conclude that in CD3-stimulated 
cells, tyrosine-phosphorylated Syk and ZAP-70 bind to p56  ~k 
by an  SH2-mediated  interaction. 
Syk- and ZAP-70-mediated Interaction of  p56  l'~ with the Ac- 
tivated TCR/CD3/~" Complex.  ZAP-70  as well  as  Syk is 
recruited to the TCK by association with tyrosine-phosphor- 
ylated CD3 and  ~" chains  (references  7,  12,  22,  and 33 and 
our own unpublished  results).  Indeed,  using a sensitive in 
vitro kinase assay, the presence of Syk and ZAP-70 together 
with CD3/~" chains could be detected in anti-p56  ~  immuno- 
precipitates  of activated Jurkat  cells  (Fig.  4/3,  lanes  I  and 
2).  This detection was abolished in the presence of a tyro- 
sine-phosphorylated peptide containing  the sequence YEEI 
(Fig. 4 B, compare lanes 2 and 3).  Conversely, the associa- 
tion of radioactively labeled p56  ~k with anti-~" immunopre- 
cipitates  of activated cells  was significantly  reduced in  the 
presence of the competitor  peptide,  whereas the  detection 
of ~'-associated  ZAP-70 and Syk was essentially unaffected 
(Fig. 4  B,  lanes  4-6),  possibly because this  association  is 
mediated by the binding of two SH2 domains to a doubly 
tyrosine-phosphorylated  AKAM  on  the  ~" chain  (21,  23). 
The slightly lower degree of CD3/g" phosphorylation in the 
in vitro kinase assay seen in the presence of the competitor 
peptide  (Fig.  4  B,  compare lanes  5  and  6)  most  probably 
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the SH2 domain of p56  ~k. (A) 107 unstimulated Jurkat cells (-) or 107 
cells stimulated with anti-CD3 for 2 rain (+) were lysed in Brij 96 lysis 
buffer containing 100 #M unphosphorylated  or tyrosine-phosphorylated 
(*) peptide EPQYEEIPI. Proteins associated  with Sepharose-coupled  MBP 
SH2 and anti-p56  ~k immunoprecipitates performed with antisera directed 
against the NH2- (NT) or COOH- (CT) terminal regions of the p56  t'k 
protein were separated  by 8% SDS-PAGE  and analyzed  by antiphosphotyro- 
sine immunoblotting. Positions of molecular mass markers are shown in 
kilodaltons. (B) 107 unstimulated  Jurkat cells (-) or 107 cells stimulated 
with anti-CD3 for 2 min (+) were lysed in Brij 96 lysis buffer containing 
100 #M unphosphorylated  or tyrosine-phosphorylated  (*) peptide  EP- 
QYEEIPI.  Anti-p56  ~k (to  the COOH-terminal region)  and anti-~"  im- 
munoprecipitates  were incubated  in an in vitro kinase assay with  [3" 
32p]ATP, and phosphorylated proteins were analyzed by 12% SDS-PAGE, 
KOH  treatment,  and autoradiography.  The positions  of p56~,  ZAP- 
70/Syk (distinguishable by reimmunoprecipitation  as shown in Fig. 1 B, 
but not resolved on a 12% gel),  the CD3, and ~" chains are indicated. 
SH2 domain binds directly to tyrosine-phosphorylated ZAP-70 
(24)  and Syk (data  not  shown),  and they argued against 
tyrosine-phosphorylated  CD3/~"  binding  directly  to  the 
p56  t~ SH2 domain (see Discussion). 
Together, these results suggest an activation-dependent as- 
sociation of p56  ~k with ~'/ZAP-70  and ~'/Syk, most likely 
mediated by the binding of tyrosine-phosphorylated  ZAP-70 
or Syk to the SH2 domain of p56  ~. 
SH2-mediated Interaction of p56~k/CD4 with the Activated 
TCR Complex.  It is weU established  that a large fraction 
of p56  ~k binds to CD4 (reviewed by Rudd et al.  [34]).  To 
test  whether CD4-associated  p56  ~  is  involved  in the de- 
scribed SH2-mediated interaction with ZAP-70 and Syk, we 
analyzed anti-CD4 immunoprecipitates for the presence of 
ZAP-70 and Syk by antiphosphotyrosine immunoblotting 
(Fig. 5). Indeed, CD4-associated p56  kk interacts  with tyro- 
sine-phosphorylated Syk and ZAP-70 after activation (Fig. 
5,  compare both  +  lanes). 
It has been proposed that the binding of the SH2 domain 
of CD4-associated p56  ~k to tyrosine-phosphorylated  proteins 
within the activated TCR complex may lead to the assembly 
of a signaling complex (28).  One prediction of this model 
would be an activation-dependent association of CD4 with 
the TCR. We have studied the influence of T cell activation 
on TCR/CD4 association by biotinylation of call surface pro- 
teins. After cell surface labding, ceils were kept unstimulated 
or activated with an anti-CD3 antibody. Immunoprecipitates 
of CD4 and the TCR 3 chain from lysates of surface-labeled 
ceils were subjected to SDS-PAGE under reducing and non- 
reducing conditions and analyzed by Western blotting with 
streptavidin-biotinylated horseradish peroxidase complex (Fig. 
6 A). Using this technique, CD4 and the TCR ot and B chains 
were clearly detected in anti-CD4 and anti-TCR V3 precipi- 
tates,  respectively  (Fig.  6 A,  lanes  3-9).  In  addition,  an 
activation-dependent coprecipitate of a fraction of CD4 with 
the  TCR  was  detected in  CD4 +  but  not  in  the  corre- 
sponding CD4- Jurkat cells (Fig. 6 A, compare lanes 3 and 
4 with lanes I and 2). We also detected an activation-dependent 
association  of a small fraction of a 63-67-kD band, likely 
to correspond to CD5  (references 35 and 36  and data not 
shown), with the TCR in CD4 § or CD4- Jurkat cells (Fig. 
6 A, lanes 1-4). The CD4 + and CD4- Jurkat clones used 
for this experiment expressed at their cell surface comparable 
amounts of CD3, and CD3-cross-linking led to indistinguish- 
able early (i.e., increase in intracellular  Ca  z+, tyrosine phos- 
results from the  reduced level of associated  p56  Ic~, which 
may contribute to the overall phosphorylation of CD3/~" in 
the assay. The tyrosine-phosphorylated  peptide did not affect 
the levels of phosphorylated ~" and CD3 chains detected in 
anti-ZAP-70 and anti-Syk immunoprecipitates  by antiphos- 
photyrosine blotting (data not shown). Thus, the tyrosine- 
phosphorylated peptide specifically competes for the p56~U 
ZAP-70  and  p5CUSyk interaction.  Although we  cannot 
formally exclude the possibility of a direct p56~U~  " associa- 
tion, our previous findings (24) demonstrated that the p56  ~k 
Figure 5.  Syk and ZAP-70 as- 
sociate with p56~k/CD4. 107 un- 
stimulated Jurkat cells (-) or 107 
cells stimulated  with anti-CD3 for 
1.5 rain (+) were lysed in Brij 96 
lysis buffer. Anti-p56  k~  (to  the 
COOH-terminal  region) and anti- 
CD4  (B66.6.1) immunoprecipi- 
tates were separated by 8% SDS- 
PAGE  and  analyzed  by  anti- 
phosphotyrosine  immunoblot- 
ting. Arrows indicate the positions 
of ZAP-70 and Syk. 
2001  Thome et al. 2  and 4), but not the low basal level of association in un- 
stimulated cells (compare lanes 1, 3, and 4). Moreover, a shorter 
exposure of the blot shows that no change was detected in 
the total CD4 present in the cell lysate before or after activa- 
tion in the presence of the phosphorylated peptide  (Fig.  6 
B, lanes 5-8).  Note that  the association of the TCK with 
the 63-67-kD band likely to correspond to CD5 did not ap- 
pear to be affected by the tyrosine-phosphorylated peptide 
(Fig.  6 B, lanes  I-4);  therefore, this  association is unlikely 
to be mediated by the same mechanism  as the TCK/CD4 
association. 
Together,  these  results  suggest  that  upon  activation, 
p56~k/CD4 associates with the activated TCK/CD3/~" com- 
plex by an SH2-mediated interaction, most likely involving 
the binding of p56  ~k SH2 to tyrosine-phosphorylated ZAP-70 
or Syk. 
ZAP-70  Cocaps with  CD4 in Activated  T  Cells.  To pro- 
vide evidence in intact cells for the occurrence of the activation- 
mediated associations of signaling molecules described here, 
we  examined  the  intraceUular  redistribution  of p56  ~k and 
ZAP-70 after antibody-mediated CD3 and CD4 capping. Be- 
cause of the rapid internalization of CD3 caps and the high 
level of p56  ~  in Jurkat cells (data not shown), a human PBL- 
Figure 6.  SH2-mediated  interaction of p56~/CD4 with the activated 
TCK comply. (A) CD4 + or CD4- Jurkat cells were surface  biotinylated, 
and Brij 96 lysates were prepared from 10  v  Jurkat cells  before (-) or after 
(+) stimulation with anti-CD3 for 1.5 rain. Immunoprecipitates  with an- 
tibodies directed  against CD4 (19Thy-5D7)  and TCR V~ (9H5) were sepa- 
rated by 7% SDS-PAGE  under nonreducing (NR) or by 10% SDS-PAGE 
under reducing (R) conditions, transferred  to nitrocellulose,  and revealed 
with streptavidin-biotinylated  horseradish peroxidase  complex. A longer 
exposure is shown for lanes 1-4 (3 min) compared with lanes 5 and 6 
(20 s) and for lanes 7 and 8 (2 min) compared with lane 9 (10 s). The 
positions  of  CD5 (determined  by comparison  with an anti-CD5 immuno- 
precipitation; data not shown), CD4, and the TCK c~ chains are indi- 
cated. Positions  of molecular mass markers are shown in kilodaltons. (B) 
Same as in A, but lysates were prepared in Brij 96 lysis buffer containing 
500 #M unphosphorylated or tyrosine-phosphorylated  (') peptide EP- 
QEEIPI. Samples were analyzed on a 7% SDS gel under nonreducing 
(NR) conditions. Exposition times were identical for all lanes, but only 
30% of the sample was loaded for anti-CD4 immunoprecipitates. 
phorylation of cellular proteins) and late (i.e., IL-2 secretion) 
events  of  activation  (data  not  shown).  The  activation- 
dependent association of CD4 with the TCR was confirmed 
by the presence of a  small proportion of TCR  ot/~ chains 
coprecipitating with CD4 from activated cells (Fig. 6 A, lanes 
7-9;  not visible in lanes 5  and  6 because only 30%  of the 
samples  were loaded). 
As has been shown, a tyrosine-phosphorylated peptide con- 
taining  the  sequence  YEEI  efficiently  competed  for  the 
p56~k/ZAP-70  or  p56~k/Syk  interaction  without  affecting 
the  ~'/ZAP-70  or  ~'/Syk  interaction  (Fig.  4  and  data  not 
shown). Fig. 6 B shows that the same tyrosine-phosphorylated 
peptide, but  not  the corresponding  unphosphorylated  ver- 
sion,  was  able to outcompete the  activation-dependent  as- 
sociation of CD4 with  the TCK (Fig.  6 B, compare lanes 
Figure 7.  ZAP-70  cocaps with CD4 in activated T cells. Antibody- 
mediated CD3 and CD4 capping was induced on the T cell surface, and 
cells were counterstained  for phosphotyrosine,  p56  ~l', and ZAP-70. (Upper 
panels) Double indirect immunofluorescence  labeling of cell surface  CD3 
(green channel) and intracellular phosphotyrosine,  p56  kk, and ZAP-70 (red 
channel). (Lower  panels) Double indirect immunofluorescence  labeling of 
cell surface  CD4 (green channel) and intracellular ZAP-70 (red channel). 
Each cell is represented by two photographs in a column. Bar, 5 #m. 
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by double immunofluorescence in Fig. 7 (upper  panels), CD3 
capping resulted in colocalization of tyrosine-phosphorylated 
proteins. Similarly, p56  ~ and ZAP-70 were in part migrating 
in the cap region. The same results were obtained with cap- 
ping using anti-TCKc~ mAb (data not shown). 
If the association of CD4 with the TCK is mediated by 
an activation-dependent p56tck/ZAP-70  interaction,  ZAP-70 
should be found in close proximity to CD4 after CD3 stim- 
ulation. To detect such a potential association in vivo, CD4 
molecules on the surface of unstimulated or activated human 
T lymphocytes were collected into caps, and the subceUular 
distribution of ZAP-70 was analyzed (Fig. 7, lower  panels). 
In resting cells, no redistribution  of ZAP-70 was observed, 
whereas after  1 min of stimulation of the cells with anti- 
CD3 antibodies, a clear enrichment of ZApo70 under the CD4 
cap was observed. These results demonstrate the requirement 
of CD3 stimulation for ZAP-70/CD4 cocapping. 
Discussion 
T cell activation requires the recognition of MHC-presented 
peptide antigen by the TCK. During this process, CD4 and 
the TCK are thought to interact with the same MHC II mol- 
ecule in a stable ternary complex (reviewed by Janeway [26]). 
It has been demonstrated for T cell clones that cellular acti- 
vation is required to induce redistribution of CD4 into the 
proximity of the TCR, as shown by cocapping, comodula- 
tion, and fluorescence  resonance  energy transfer (37-39). How- 
ever, no direct biochemical  evidence  for an activation-dependent 
association of CD4 with the TCR/CD3/~" has been reported. 
We have shown, using cell surface biotinylation,  that in 
Jurkat cells, CD4 associates with TCR/CD3/~" after CD3 
triggering.  What is  the driving force for this  activation- 
dependent colocalization? Several  observations point to a cen- 
tral role of CD4-associated p56 ~k in  the formation of the 
multimolecular TCK/CD3/g'-CD4 complex. Collins et al. 
(27) have shown that the interaction  of p56  ~k with CD4 is 
critical for the colocalization  of CD4 with TCR/CD3/~ 
and for signal transduction.  Furthermore, coreceptor func- 
tion of p5Ck/CD4 does not seem to depend on the active 
kinase domain of p56 ~k, but rather on its SH2 or SH3 do- 
main (28, 40). Therefore, one of the functions of p56 ~k may 
be to link CD4 physically to the TCK via its SH2 or SH3 
domain. 
Our data are consistent with the idea that during T cell 
activation, CD4 associates with TCK/CD3/~" via the SH2 
domain of p56 tck and that ZAP-70 and/or Syk represent the 
molecular link between them. First, we show that a tyrosine- 
phosphorylated  peptide  which binds  with high affinity to 
the SH2 domain of p56  t~k is able to disrupt the activation- 
dependent association of CD4 with TCK/CD3/~'. Second, 
after activation, ZAP-70 and Syk can be coimmunoprecipitated 
with CD4. Third, we show that under the same conditions, 
p56 ~k binds to ZAP-70 and Syk and that this interaction can 
be prevented by the presence of the same tyrosine-phosphor- 
ylated peptide; moreover, binding of ZAP-70 (24) and Syk 
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to a recombinant SH2 domain of p56  ~  was demonstrated. 
Fourth, by in vitro kinase assay, we have detected the associ- 
ation of ~" with p56~/Syk and p5C~/ZAP-70 and, vice  versa, 
the association of p56  ~k with ~" in anti-~"  immunoprecipitates 
in the course of CD3 stimulation of  Jurkat cells. The tyro- 
sine-phosphorylated peptide was able to compete specifically 
for the p56kk/ZAP-70 and p56~k/Syk interactions  without 
affecting the ~'/ZAP-70 and ~'/Syk interactions. Finally, ex- 
periments in intact cells using T lymphoblasts provided ad- 
ditional support to these findings, p56 ~k was shown to cocap 
with CD3 rapidly upon activation, which is in agreement 
with recent data from Ley et al. (41), who also found p56fr" 
not to be localized at the plasma membrane. Also, in separate 
experiments, we observed that ZAP-70 colocalizes  with CD3 
or CD4 only after activation. Although the immunofluores- 
cence experiments provide correlative evidences,  together they 
are consistent with an activation-induced  redistribution of 
p56tck/CD4 in the vicinity of ZAP-70 bound to the TCR/ 
CD3/~" complex. 
In accordance with our results, it has been shown that the 
expression of ~" in the TCK/CD3 complex is of critical im- 
portance for p56~k/CD4-mediated up-regulation of TCK/ 
CD3 signaling in the human leukemic T cell line HBP-ALL 
(42). Moreover, Dianziani et al. (43) have  reported that tyro- 
sine phosphorylation of the ~" chain parallels the physical as- 
sociation of CD4 and the TCK in a murine T  cell clone. 
Our previous findings (24) demonstrated that the p56/`~ 
SH2 domain binds directly to tyrosine-phosphorylated  ZAP-70 
and to a p74 tyrosine-phosphorylated  protein (identified here 
as being Syk) and argued against a direct binding to tyrosine- 
phosphorylated  CD3/~" chains. Using the p56  ~k SH2  do- 
main as a probe in far Western blot experiments,  tyrosine- 
phosphorylated ZAP-70 (24) and Syk (data not shown) could 
be directly recognized, whereas CD3/~" was barely detect- 
able (24). Moreover, in cell  lysates from activated  Jurkat cells, 
the p56  ~k SH2 domain readily precipitated  tyrosine-phos- 
phorylated ZAP-70 and p74 (Syk), whereas only little tyrosine- 
phosphorylated  CD3/~" was detectable, even though it was 
abundantly present in anti-~"  immunoprecipitates  (24). The 
most likely interpretation of this  result  is  that  the small 
amount of tyrosine-phosphorylated  CD3/~" observed with 
the p56  ~k SH2 domain corresponds to the fraction bound to 
ZAP-70 and Syk. Indeed, the ratio of tyrosine-phosphorylated 
ZAP-70 to  CD3/~" in anti-ZAP-70  immunoprecipitates  is 
similar to that detected with the p56  ~k SH2 domain (24). 
In addition,  we have shown that the presence of CD3/~" is 
not required for the p56  ~k SH2-mediated binding of ZAP-70 
and Syk, since depletion of CD3/~" from a lysate of activated 
cells does not prevent binding of the remaining ZAP-70/Syk 
to the p56  t~k SH2 domain (24). In accordance with our re- 
suits, Wange et al. (23) have recently demonstrated the pre- 
ferential binding of ~" and CD3e chains by ZAP-70 (SH2)z 
domains, whereas the p56  t`k SH2 domain preferentially binds 
to a p70 phosphoprotein. Moreover,  Iwashima et al. (21), using 
activated  Jurkat ceils, have demonstrated binding of ZAP-70, 
but not of p56 ~, to a doubly tyrosine-phosphorylated  pep- 
tide encompassing a ~" ARAM. Together, these results argue 
against a direct SH2-mediated binding of p56 ~k to CD3/~'. MHC II 
o/n  v, 
ZAP-70 
Figure  8.  Hypothetical model of the recruitment of CD4  to  the 
TCR/CD3/~" complex. T cell receptor stimulation by MHC-bound an- 
tigen leads to tyrosine phosphorylation of the CD3/~" chains and recruit- 
ment and tyrosine  phosphorylation of the Syk or ZAP-70  tyrosine  kinase. 
Binding of the SH2 domain of p56  t'k to a phosphotyrosine residue on 
ZAP-70 or Syk (1) may then recruit CD4 to the activated TCR/CD3/~" 
complex (2) and stabilize the interaction with the antigen-presenting MHC 
II molecule. 
In view of our results and based on a previous model by 
Xu and Littman (28), we propose that the interaction of the 
SH2 domain of p56 ~k with CD3/~'-associated ZAP-70 and 
Syk enables the TCR/CD3/~" complex to associate with the 
CD4 coreceptor (Fig. 8). This implies that a primary encounter 
of the TCR with the antigen/MHC II should lead to a par- 
tial activation (i.e., tyrosine phosphorylation of CD3/~'chains 
and binding of ZAP-70 and/or Syk) of the TCK complex, 
which may then recruit p5CUCD4  with  the consequence 
of (a)  a physical  stabilization,  by CD4,  of the  TCR/an- 
tigen/MHC interaction and (b) an increased tyrosine phos- 
phorylation of TCR-associated signaling molecules by p56  ~, 
thereby further  amplifying  the signaling  process. 
An interesting consequence of such a inodel is that CD4 
would be preferentially recruited by the rare TCRs success- 
fully engaged with the small number of specific ligands avail- 
able on an antigen-presenting cell (44), resulting in an efficient 
recognition/signal  transduction  process. 
A  direct  physical  interaction  between CD4  and  TCR/ 
CD3/~" has been reported to occur independently of activa- 
tion in T  cell clones (45, 46), in tumor cell lines (47), and 
in freshly isolated T  cells (48, 49).  We have also observed 
a low level of association of CD4 with the TCK in Brij 96 
lysates  of unstimulated Jurkat cells,  but in contrast  to the 
association seen for activated cells, the former does not seem 
to be mediated by the same p56  t'k SH2-mediated interaction, 
since  it  was  not  disrupted  in  the  presence  of a  tyrosine- 
phosphorylated competitor peptide. 
Our  data  indicate  that,  in Jurkat  ceils,  both  tyrosine- 
phosphorylated ZAP-70 and Syk bind to the SH2 domain 
of p56  ~k and that one consequence of this interaction is the 
association  of  p56~UCD4  with  activated  TCR/CD3/~'. 
This is probably not surprising considering the structural ho- 
mology of these two PTKs (50).  What are the relative con- 
tributions of ZAP-70 and Syk to this process? We show, by 
immunodepletion  experiments,  that ZAP-70 and Syk bind 
to separate  cellular pools of p56~k  This suggests that both 
kinases can contribute independently to the activation-depen- 
dent association of p56~UCD4 with  the TCR/CD3  com- 
plex.  Different  affinities  of the  SH2 domain  of p56 ~t' for 
tyrosine-'phosphorylated Syk and ZAP-70 and differences in 
their level of expression, tyrosine phosphorylation, and CD3/~" 
association may influence their respective importance for the 
clustering of CD4 and TCR/CD3 in distinct T cell subsets 
or in T  cells of differing developmental stages.  Indeed, sev- 
eral lines of evidence indicate that the functions of ZAP-70 
and Syk are not redundant.  First, the expression of ZAP-70 
and Syk is developmentally regulated: Syk is expressed at higher 
levels in the thymus and lower levels in peripheral  T  cells 
and ZAP-70 is expressed at roughly equivalent levels in thymus 
and periphery (12). Furthermore, ZAP-70-deficient SCID pa- 
tients lack peripheral CD8 + T  cells and have normal num- 
bers of circulating CD4 + T cells that are deficient in TCR- 
mediated signaling  (10,  11, 51).  These results suggest that 
Syk-mediated signaling may play a dominant role for thymic 
maturation  of CD4 + T  cells,  whereas ZAP-70 is essential 
for signaling  in mature CD4 + T  cells. 
Although further studies of signaling events in T cells of 
different functional or developmental stages are necessary to 
elucidate the individual roles of the Syk/ZAP-70  kinases, our 
data indicate that  the mechanism  of their coupling  to the 
TCR and CD4 is essentially identical. 
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